Molecular Partners Ag (MOLN) Return on Sales [ROS] (2020 - 2026)
Molecular Partners Ag's Return on Sales [ROS] was -7946.55% in Q2 2026, down 10594.88 percentage points from 2648.33% a year earlier.
Powered by 
Analysis
Molecular Partners Ag (MOLN) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
For FY2024, Return on Sales [ROS] at Molecular Partners Ag came in at 1224.00%, up 2092.26 percentage points from FY2023.
- Return on Sales [ROS] shows a five-year change of +1403.86 percentage points (FY2019 to FY2024).
- In earlier years, Return on Sales [ROS] was -868.26% in FY2023 (-929.76 pp), 61.50% in FY2022 (+711.68 pp), -650.17% in FY2021 (-25.97 pp) and -624.21% in FY2020 (-444.35 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Sales [ROS] in data going back to Q3 2020.
- Compared with a year earlier, Return on Sales [ROS] was higher in two of the last four quarters, with an average year-over-year change of +87957.14 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2024 (a gain of 360356.51 percentage points); the worst was Q2 2026 (a drop of 10594.88 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 28.37% |
| 10 | Molecular Partners Ag | 136.79 Mn | -294.45 Mn | - | -8,296.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8,296.59% |
| Jun 30, 2025 | -2,902.62% |
| Dec 31, 2024 | -1,233.79% |
| Sep 30, 2024 | -2,142.29% |
| Jun 30, 2024 | -1,030.05% |
| Mar 31, 2024 | -579.18% |
| Dec 31, 2023 | -1,613.18% |
| Sep 30, 2023 | -530.85% |
| Jun 30, 2023 | -3,827.23% |
| Mar 31, 2023 | -494.69% |
| Dec 31, 2022 | -554.71% |
| Sep 30, 2022 | -621.49% |
| Jun 30, 2022 | -53.52% |
| Mar 31, 2022 | 88.29% |
| Dec 31, 2021 | -875.17% |
| Sep 30, 2021 | -363.35% |
| Jun 30, 2021 | -472.76% |
| Mar 31, 2021 | -1,896.62% |
| Dec 31, 2020 | -6,251.72% |
| Sep 30, 2020 | 5,360.78% |
API Access
Molecular Partners Ag Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();